Dr Reddy's, Endo get USFDA approval to launch antiviral Valcyte
The move comes after Ranbaxy Labs said on Thursday that FDA had stripped the company of its tentative approval to launch the first copy of the drug due to quality control issues at its plants.
Mumbai Last Updated: November 7, 2014 | 10:47 IST
Photo for representation purposes only. (Source: Reuters)